Cite

HARVARD Citation

    Duong, V. et al. (2013). Multikinase inhibitors for treating high-risk myelodysplastic syndromes: can this be brought into clinical practice?. Expert review of hematology. 6 (5), pp. 485-487. [Online]. 
  
Back to record